FDA Approved: NEXOBRID — Original Application (Vericel Corporation)

View source ↗

Summary

FDA approval of NEXOBRID (ANACAULASE-BCDB) from Vericel Corporation as an original application for enzymatic debridement of burn wounds.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burn Injuries

Drugs mentioned

• NEXOBRID (ANACAULASE-BCDB)

Snippet

ORIG AP for NEXOBRID (ANACAULASE-BCDB)